Zimmer Biomet Holdings (NYSE:ZBH) has had a rough month with its share price down 5.4%. However, stock prices are usually driven by a company’s financials over the long term, which in this case look ...

Principal Financial Group Inc. lowered its stake in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Free Report) by 4.0% ...

Zimmer Biomet ZBH has been facing a difficult macroeconomic situation, which has raised expenses. Its leveraged capital ...

Principal Securities Inc. boosted its position in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Free Report) by 23.7% in ...

Zimmer Biomet Holdings, Inc. (ZBH) is a global medical technology company specializing in musculoskeletal healthcare ...

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products ...

The upcoming report from Zimmer Biomet (ZBH) is expected to reveal quarterly earnings of $2.30 per share, indicating an increase of 4.6% compared to the year-ago period. Analysts forecast revenues ...

In a report released today, Ryan Zimmerman from BTIG maintained a Buy rating on Zimmer Biomet Holdings (ZBH – Research Report), with a price ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

1 Day ZBH 0.19% DJIA -1.41% S&P 500 -0.75% Health Care/Life Sciences -0.28% ...